The LORICRIN gene makes loricrin, a major protein in the outermost layer of skin. This gene helps your body build a strong skin barrier that keeps moisture in and irritants out. If a pathogenic variant disrupts this process, a person may develop an inherited skin condition with thickened skin on the palms and soles, dry or scaly skin, and sometimes tight bands around fingers or toes. The LORICRIN gene is mainly known in dermatology and has not had the same public attention as genes such as BRCA1 or APOE.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage processes throughout the body. Some genes provide the directions for producing proteins, which are the active components of cells. Others mostly help regulate when certain processes happen, where they happen, and how strongly they occur. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. To go into this topic in greater detail, you can find more in the LearnHub.
Overview
LORICRINGene function
What if the gene works
The LORICRIN gene helps make loricrin, a key protein in the outer skin layer. It supports a tough, water-resistant barrier that protects against irritation, germs, and water loss.
Risk
What if the gene does not work
Variants in the LORICRIN gene can lead to inherited skin changes, most often thickened skin on the palms and soles with dry, scaly skin elsewhere. Milder or more severe variants may affect when symptoms begin and how noticeable they are.
Treatment
What does that mean for your treatment
No LORICRIN-specific treatment or management approach is currently established. Treatment is based on skin symptoms rather than the exact variant, and the LORICRIN gene is mainly being studied in skin barrier research rather than as a direct drug target.
Conditions associated with LORICRIN
Gene function
What if the gene works
Your skin depends on the LORICRIN gene to build a tough outer surface that holds moisture in and helps block everyday irritants. It is most active in skin cells as they reach their final stage and form the body’s outer barrier. Understanding how the LORICRIN gene supports the skin barrier helps explain how skin stays resilient in daily life.
The LORICRIN gene becomes active late as skin cells complete their final step before joining the surface. Its protein helps turn these cells into flat, durable cells that make up the protective outer layer.
Its protein forms a major part of the tough coating around mature skin cells. This gives the skin surface added strength and helps it stand up to rubbing, washing, and day to day wear.
By strengthening the outer barrier, the LORICRIN gene helps reduce water loss from the skin surface. It supports the seal that keeps moisture in while limiting the entry of everyday irritants from the environment.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many disease linked changes in the LORICRIN gene alter the tail end of loricrin, making the protein abnormally long and rich in arginine, a protein building block that can pull it into the cell nucleus instead of the outer skin layer. This helps explain how LORICRIN gene variants affect the skin barrier at a cellular level. Milder variants may partly reduce normal protein joining, while more disruptive variants more strongly misdirect the protein and can be linked to earlier or more noticeable skin changes.
How variants are linked to conditions
Pathogenic variants in the LORICRIN gene cause loricrin keratoderma, a rare inherited skin condition marked by thickened skin on the palms and soles and often dry, scaly skin elsewhere. This LORICRIN gene skin condition has also been described historically as Camisa syndrome or as a form of Vohwinkel syndrome without hearing loss. When a disease-causing variant is found, it can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LORICRIN, risk is mainly shaped by whether an inherited gene change is present, so family history is the biggest factor. There is not enough evidence to say lifestyle changes lower the chance of having the condition, but dry skin, friction, and pressure on the hands and feet can make symptoms more noticeable.
Inheritance of LORICRIN variants
LORICRIN gene inheritance for the best-known related skin condition is autosomal dominant. This means a person with a disease-causing variant in one copy of the LORICRIN gene can pass it to a child, with a 1 in 2, or 50%, chance in each pregnancy. Sons and daughters are affected at the same rate, and either parent can pass the variant on. In families with LORICRIN-related keratoderma, the pattern often appears across several generations.
What does my LORICRIN result mean for my family?
A disease-causing result in the LORICRIN gene is usually linked to a dominantly inherited skin condition, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change. In practical terms, this can mean similar lifelong skin changes in more than one family member, even if symptoms are milder or look a bit different from person to person. Because of that, first-degree relatives often consider learning whether they have the same result.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant, LORICRIN genetic testing uses a blood or saliva sample to read the DNA in the LORICRIN gene. This is how doctors test for LORICRIN variants linked to inherited skin thickening, with results usually classified as pathogenic, benign, or uncertain.
When should I consider getting a genetic test?
Genetic testing for the LORICRIN gene may be worth considering if you or close relatives have an inherited pattern of very thick skin on the palms and soles, widespread dry scaly skin, or tight bands around fingers or toes. It can help confirm whether LORICRIN-related skin disease runs in the family.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, yet how much they reveal depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as response to medications, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to drugs differently. These differences are common and can influence how strongly a medicine works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It explores links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence how powerfully a drug works or how the body handles it. This information can support treatment choices that are more informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the LORICRIN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which treatment is best. Questions about symptoms, skin changes, medicines, or side effects are best discussed with your doctor or pharmacist.
History
Researchers identified loricrin in the late 1980s while studying how the outer layer of skin is formed and maintained. Soon after, the LORICRIN gene was mapped to a region of chromosome 1 that contains several genes important for skin development. From these first observations, research expanded steadily. In the 1990s, scientists linked changes in the LORICRIN gene to an inherited skin condition now called loricrin keratoderma, helping explain why some families shared thickened skin on the hands and feet. That work also sharpened the understanding of related conditions that had previously been grouped together based mainly on appearance.